These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 16937498)

  • 1. Effects of chronic therapy with non-steroidal antiinflammatory drugs on gastric permeability of sucrose: a study on 71 patients with rheumatoid arthritis.
    Maino M; Mantovani N; Merli R; Cavestro GM; Leandro G; Cavallaro LG; Corrente V; Iori V; Pilotto A; Franzè A; Di Mario F
    World J Gastroenterol; 2006 Aug; 12(31):5017-20. PubMed ID: 16937498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of pantoprazole compared with misoprostol for the prevention of NSAID-related gastrointestinal lesions and symptoms in rheumatic patients.
    Stupnicki T; Dietrich K; González-Carro P; Straszak A; Terjung A; Thomas KB; Lühmann R; Fischer R
    Digestion; 2003; 68(4):198-208. PubMed ID: 14707396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of protection by pantoprazole against NSAID-induced gastric mucosal damage.
    Fornai M; Natale G; Colucci R; Tuccori M; Carazzina G; Antonioli L; Baldi S; Lubrano V; Abramo A; Blandizzi C; Del Tacca M
    Naunyn Schmiedebergs Arch Pharmacol; 2005 Jul; 372(1):79-87. PubMed ID: 16080005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intragastric acid control in non-steroidal anti-inflammatory drug users: comparison of esomeprazole, lansoprazole and pantoprazole.
    Goldstein JL; Miner PB; Schlesinger PK; Liu S; Silberg DG
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1189-96. PubMed ID: 16611280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonsteroidal anti-inflammatory drugs: add an anti-ulcer drug for patients at high risk only. Always limit the dose and duration of treatment with NSAIDs.
    Prescrire Int; 2011 Sep; 20(119):216-9. PubMed ID: 21954519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonsteroidal anti-inflammatory drug use does not affect short-term endoscopic and histologic outcomes after Helicobacter pylori eradication in patients with rheumatoid arthritis.
    Tanaka E; Kamitsuji S; Inoue E; Yamada T; Nakajima A; Takeuchi E; Yanagisawa A; Misaka R; Shigemoto M; Yamashita K; Imamura T; Hara M; Tomatsu T; Saito T; Lauren G; Triadafilopoulos G; Kamatani N; Singh G; Yamanaka H
    Mod Rheumatol; 2007; 17(3):228-34. PubMed ID: 17564779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of NSAID-associated gastrointestinal lesions: a comparison study pantoprazole versus omeprazole.
    Regula J; Butruk E; Dekkers CP; de Boer SY; Raps D; Simon L; Terjung A; Thomas KB; Lühmann R; Fischer R
    Am J Gastroenterol; 2006 Aug; 101(8):1747-55. PubMed ID: 16817839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of pantoprazole on ulcer healing delay associated with NSAID treatment.
    Fornai M; Colucci R; Antonioli L; Ghisu N; Tuccori M; Blandizzi C; Del Tacca M
    Naunyn Schmiedebergs Arch Pharmacol; 2009 Mar; 379(3):305-13. PubMed ID: 18853145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of NSAID gastropathy in elderly patients. An observational study in general practice and nursing homes.
    van Leen MW; van der Eijk I; Schols JM
    Age Ageing; 2007 Jul; 36(4):414-8. PubMed ID: 17537740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healing of NSAID-induced gastric ulcers with a synthetic prostaglandin analog (enprostil).
    Sontag SJ; Schnell TG; Budiman-Mak E; Adelman K; Fleischmann R; Cohen S; Roth SH; Ipe D; Schwartz KE
    Am J Gastroenterol; 1994 Jul; 89(7):1014-20. PubMed ID: 8017358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs.
    Taha AS; Hudson N; Hawkey CJ; Swannell AJ; Trye PN; Cottrell J; Mann SG; Simon TJ; Sturrock RD; Russell RI
    N Engl J Med; 1996 May; 334(22):1435-9. PubMed ID: 8618582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for the development of gastric mucosal lesions in rheumatoid arthritis patients receiving long-term nonsteroidal anti-inflammatory drug therapy and the efficacy of famotidine obtained from the FORCE study.
    Kobata Y; Yajima H; Yamao J; Tanaka Y; Fukui H; Takakura Y
    Mod Rheumatol; 2009; 19(6):629-36. PubMed ID: 19728013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sucrose permeability as a marker for NSAID-induced gastroduodenal injury.
    Erlacher L; Wyatt J; Pflugbeil S; Köller M; Ullrich R; Vogelsang H; Smolen JS; Graninger W
    Clin Exp Rheumatol; 1998; 16(1):69-71. PubMed ID: 9543566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastric emptying of solids in long-term NSAID users: correlation with endoscopic findings and Helicobacter pylori status.
    Kulkarni SG; Parikh SS; Shankhpal PD; Desai SA; Borges NE; Desai SB; Vora IM; Kalro RH
    Am J Gastroenterol; 1999 Feb; 94(2):382-6. PubMed ID: 10022633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventive therapy for non-steroidal anti-inflammatory drug-induced ulcers in Japanese patients with rheumatoid arthritis: the current situation and a prospective controlled-study of the preventive effects of lansoprazole or famotidine.
    Miyake K; Ueki N; Suzuki K; Shinji Y; Kusunoki M; Hiratsuka T; Nishigaki H; Tatsuguchi A; Futagami S; Wada K; Tsukui T; Nakajima A; Yoshino S; Sakamoto C
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():67-72. PubMed ID: 15943850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pantoprazole: an update of its pharmacological properties and therapeutic use in the management of acid-related disorders.
    Cheer SM; Prakash A; Faulds D; Lamb HM
    Drugs; 2003; 63(1):101-33. PubMed ID: 12487624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-Helicobacter pylori ulcer disease in rheumatoid arthritis patients receiving long-term NSAID therapy.
    Mizokami Y; Narushima K; Shiraishi T; Otsubo T; Narasaka T; Matsuoka T
    J Gastroenterol; 2000; 35 Suppl 12():38-41. PubMed ID: 10779216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between anti-ulcer drugs and non-steroidal anti-inflammatory drugs in cirrhotic patients with bleeding esophagogastric varices.
    Yoshida H; Mamada Y; Taniai N; Mineta S; Kawano Y; Mizuguchi Y; Kakinuma D; Kanda T; Tajiri T
    Hepatogastroenterology; 2009; 56(94-95):1366-70. PubMed ID: 19950793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lansoprazole prevents experimental gastric injury induced by non-steroidal anti-inflammatory drugs through a reduction of mucosal oxidative damage.
    Blandizzi C; Fornai M; Colucci R; Natale G; Lubrano V; Vassalle C; Antonioli L; Lazzeri G; Del Tacca M
    World J Gastroenterol; 2005 Jul; 11(26):4052-60. PubMed ID: 15996031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Helicobacter pylori in NSAID users with gastric ulcer.
    Matsukawa Y; Aoki M; Nishinarita S; Sawada S; Horie T; Kato K; Kawamura Y; Kawamura F; Arakawa Y; Kurosaka H; Morita K; Ohtsuka E; Oribe M; Nakano M; Kitami Y
    Rheumatology (Oxford); 2003 Aug; 42(8):947-50. PubMed ID: 12730504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.